RBC Capital Markets Reiterates Outperform Rating for CRH Medical Corp (CRHM)
CRH Medical Corp (NASDAQ:CRHM)‘s stock had its “outperform” rating reiterated by equities research analysts at RBC Capital Markets in a research note issued to investors on Saturday. They currently have a $6.50 price target on the stock. RBC Capital Markets’ price objective would suggest a potential upside of 50.46% from the stock’s current price.
Several other analysts have also commented on CRHM. Canaccord Genuity reissued a “buy” rating on shares of CRH Medical Corp in a report on Monday, July 11th. Zacks Investment Research lowered CRH Medical Corp from a “buy” rating to a “hold” rating in a report on Monday, September 5th. Finally, CIBC restated an “outperform” rating on shares of CRH Medical Corp in a research report on Tuesday, September 13th.
CRH Medical Corp (NASDAQ:CRHM) opened at 4.32 on Friday. The firm has a 50-day moving average price of $3.80 and a 200 day moving average price of $3.55. CRH Medical Corp has a 12 month low of $2.15 and a 12 month high of $4.39.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/08/rbc-capital-markets-reiterates-outperform-rating-for-crh-medical-corp-crhm.html
Several institutional investors have recently added to or reduced their stakes in CRHM. Hillsdale Investment Management Inc. purchased a new position in CRH Medical Corp during the second quarter valued at $3,661,000. Stifel Financial Corp purchased a new position in CRH Medical Corp during the second quarter valued at $3,051,000. Pacific Ridge Capital Partners LLC purchased a new position in CRH Medical Corp during the second quarter valued at $1,985,000. Mackenzie Financial Corp purchased a new position in CRH Medical Corp during the second quarter valued at $1,899,000. Finally, Bank of Montreal Can purchased a new position in CRH Medical Corp during the second quarter valued at $1,258,000.
CRH Medical Corp Company Profile
CRH Medical Corporation, formerly Medsurge Medical Products Corp., is a healthcare products and services company. The Company operates through segments, including the sale of medical products and the provision of anesthesia services. The Company specializes in the treatment of hemorrhoids utilizing its treatment protocol and technology.
Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.